Literature DB >> 1940953

Penicillamine treatment of Wilson's disease and optic neuropathy.

A H Lee, N F Lawton.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1940953      PMCID: PMC1014489          DOI: 10.1136/jnnp.54.8.746

Source DB:  PubMed          Journal:  J Neurol Neurosurg Psychiatry        ISSN: 0022-3050            Impact factor:   10.154


× No keyword cloud information.
  4 in total

1.  Deterioration of Wilson's disease following the start of penicillamine therapy.

Authors:  H S Pall; A C Williams; D R Blake
Journal:  Arch Neurol       Date:  1989-04

2.  Optic neuropathy associated with penicillamine therapy in a patient with rheumatoid arthritis.

Authors:  T G Klingele; R M Burde
Journal:  J Clin Neuroophthalmol       Date:  1984-06

3.  Clinical assessment of 31 patients with Wilson's disease. Correlations with structural changes on magnetic resonance imaging.

Authors:  S Starosta-Rubinstein; A B Young; K Kluin; G Hill; A M Aisen; T Gabrielsen; G J Brewer
Journal:  Arch Neurol       Date:  1987-04

4.  Sensory evoked potentials in Wilson's disease.

Authors:  N S Chu
Journal:  Brain       Date:  1986-06       Impact factor: 13.501

  4 in total
  3 in total

1.  Acute-Onset Visual Impairment in Wilson's Disease: A Case Report and Literature Review.

Authors:  Zi-Wei Zheng; Meng-Hui Xu; Chuan-Bin Sun; Zhi-Ying Wu; Yi Dong
Journal:  Front Neurol       Date:  2022-06-14       Impact factor: 4.086

2.  Bilateral Optic Neuropathy as the Prominent Manifestation of Wilson's Disease.

Authors:  Shilin Yang; Shenyi Kuang; Yiqin Xiao; Xiang Han
Journal:  J Clin Neurol       Date:  2022-07       Impact factor: 2.566

3.  Acute-Onset Optic Neuropathy in Wilson's Disease.

Authors:  Liyung Tiffany Chou; Derek Horkey; Mark Slabaugh
Journal:  Case Rep Ophthalmol       Date:  2019-01-03
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.